Results 4,381-4,400 of 4,491 for speaker:John Perry

Public Accounts Committee: Health Service Executive Financial Statements 2014
2014 Annual Report and Appropriation Accounts of the Comptroller and Auditor General
Vote 39: Health Service Executive
Chapter 19: Compliance with Prompt Payment Legislation in the Health Sector
Chapter 20: Management of Private Patient Income in the Health Sector
Chapter 21: Control over the Supply of High-Tech Drugs and Medicines (22 Oct 2015)

John Perry: I am dismayed by Deputy Fleming's point because I know as a former Minister of State that travelling, whether on business to Madrid or wherever else, that there are certain inferences about going on a trip or a conference. I have no doubt there is a record of many Oireachtas Members travelling to destinations when there was no obligation on them to do it, without the Oireachtas paying for...

Public Accounts Committee: Health Service Executive Financial Statements 2014
2014 Annual Report and Appropriation Accounts of the Comptroller and Auditor General
Vote 39: Health Service Executive
Chapter 19: Compliance with Prompt Payment Legislation in the Health Sector
Chapter 20: Management of Private Patient Income in the Health Sector
Chapter 21: Control over the Supply of High-Tech Drugs and Medicines (22 Oct 2015)

John Perry: I ask Mr. O'Brien to explain that again. Is he saying that the over estimate was outside his control?

Public Accounts Committee: Health Service Executive Financial Statements 2014
2014 Annual Report and Appropriation Accounts of the Comptroller and Auditor General
Vote 39: Health Service Executive
Chapter 19: Compliance with Prompt Payment Legislation in the Health Sector
Chapter 20: Management of Private Patient Income in the Health Sector
Chapter 21: Control over the Supply of High-Tech Drugs and Medicines (22 Oct 2015)

John Perry: Did the Comptroller and Auditor General's audit team investigate the over run?

Public Accounts Committee: Health Service Executive Financial Statements 2014
2014 Annual Report and Appropriation Accounts of the Comptroller and Auditor General
Vote 39: Health Service Executive
Chapter 19: Compliance with Prompt Payment Legislation in the Health Sector
Chapter 20: Management of Private Patient Income in the Health Sector
Chapter 21: Control over the Supply of High-Tech Drugs and Medicines (22 Oct 2015)

John Perry: That was not made clear in the Comptroller and Auditor General's report. We are talking about an over run and how the money was spent in areas that are not under the control of the HSE. We are talking about schemes that are demand led, for example. How is that not incorporated into the report?

Public Accounts Committee: Health Service Executive Financial Statements 2014
2014 Annual Report and Appropriation Accounts of the Comptroller and Auditor General
Vote 39: Health Service Executive
Chapter 19: Compliance with Prompt Payment Legislation in the Health Sector
Chapter 20: Management of Private Patient Income in the Health Sector
Chapter 21: Control over the Supply of High-Tech Drugs and Medicines (22 Oct 2015)

John Perry: In the context of services that are demand led, what are the implications for the future in terms of the HSE not receiving supplementary funding?

Public Accounts Committee: Health Service Executive Financial Statements 2014
2014 Annual Report and Appropriation Accounts of the Comptroller and Auditor General
Vote 39: Health Service Executive
Chapter 19: Compliance with Prompt Payment Legislation in the Health Sector
Chapter 20: Management of Private Patient Income in the Health Sector
Chapter 21: Control over the Supply of High-Tech Drugs and Medicines (22 Oct 2015)

John Perry: Yes.

Public Accounts Committee: Health Service Executive Financial Statements 2014
2014 Annual Report and Appropriation Accounts of the Comptroller and Auditor General
Vote 39: Health Service Executive
Chapter 19: Compliance with Prompt Payment Legislation in the Health Sector
Chapter 20: Management of Private Patient Income in the Health Sector
Chapter 21: Control over the Supply of High-Tech Drugs and Medicines (22 Oct 2015)

John Perry: Will the new system of fiscal controls not impact on the demand-led services? There is constant talk about trolleys, medical cards and so forth but if something comes down the track that is not foreseen, how will the HSE deal with it?

Public Accounts Committee: Health Service Executive Financial Statements 2014
2014 Annual Report and Appropriation Accounts of the Comptroller and Auditor General
Vote 39: Health Service Executive
Chapter 19: Compliance with Prompt Payment Legislation in the Health Sector
Chapter 20: Management of Private Patient Income in the Health Sector
Chapter 21: Control over the Supply of High-Tech Drugs and Medicines (22 Oct 2015)

John Perry: I ask the Department of Health officials to respond to a question about the new hospital groups and the autonomy that has been given to hospitals. Given that the HSE is accountable for service provision, how will this impact on the services being provided by the new hospital groups? How will it effect the deficits and budgets?

Public Accounts Committee: Health Service Executive Financial Statements 2014
2014 Annual Report and Appropriation Accounts of the Comptroller and Auditor General
Vote 39: Health Service Executive
Chapter 19: Compliance with Prompt Payment Legislation in the Health Sector
Chapter 20: Management of Private Patient Income in the Health Sector
Chapter 21: Control over the Supply of High-Tech Drugs and Medicines (22 Oct 2015)

John Perry: What are the biggest challenges for the HSE at the moment? It is easy for members to come in here and to criticise and find fault with the executive but we must bear in mind the size of the organisation, the number of staff it employs, the different services it provides, including demand-led services, HIQA inspections and so forth. I do not envy Mr. O'Brien's job. What, in his view, are...

Public Accounts Committee: Health Service Executive Financial Statements 2014
2014 Annual Report and Appropriation Accounts of the Comptroller and Auditor General
Vote 39: Health Service Executive
Chapter 19: Compliance with Prompt Payment Legislation in the Health Sector
Chapter 20: Management of Private Patient Income in the Health Sector
Chapter 21: Control over the Supply of High-Tech Drugs and Medicines (22 Oct 2015)

John Perry: I wish to refer to the issue of moving people from hospital into long-term care settings. During the recession there was a shortage of long-term care beds. The new HIQA standards dictate that ward sizes must be limited. If HIQA carries out an inspection and a facility is found to be in breach of the standards, what happens if that facility seeks funding from the HSE in order to carry out...

Public Accounts Committee: Health Service Executive Financial Statements 2014
2014 Annual Report and Appropriation Accounts of the Comptroller and Auditor General
Vote 39: Health Service Executive
Chapter 19: Compliance with Prompt Payment Legislation in the Health Sector
Chapter 20: Management of Private Patient Income in the Health Sector
Chapter 21: Control over the Supply of High-Tech Drugs and Medicines (22 Oct 2015)

John Perry: A very important issue which was debated in the public domain is the lifesaving drugs that cost €1,000 or €2,000 per week to a category of patients who are taking trial drugs. What is the position on funding new trial medicine in a situation where it is life or death?

Public Accounts Committee: Health Service Executive Financial Statements 2014
2014 Annual Report and Appropriation Accounts of the Comptroller and Auditor General
Vote 39: Health Service Executive
Chapter 19: Compliance with Prompt Payment Legislation in the Health Sector
Chapter 20: Management of Private Patient Income in the Health Sector
Chapter 21: Control over the Supply of High-Tech Drugs and Medicines (22 Oct 2015)

John Perry: We heard about the issue of small companies involved in procurement and the supply chain, the co-ordination of buying and duplication. I was previously Chairman of the committee and since I have returned to it there has always been an issue with how procurement is run and the integration of the service. While in theory it sounds easy to implement, what are the challenges in implementing it?

Public Accounts Committee: Health Service Executive Financial Statements 2014
2014 Annual Report and Appropriation Accounts of the Comptroller and Auditor General
Vote 39: Health Service Executive
Chapter 19: Compliance with Prompt Payment Legislation in the Health Sector
Chapter 20: Management of Private Patient Income in the Health Sector
Chapter 21: Control over the Supply of High-Tech Drugs and Medicines (22 Oct 2015)

John Perry: Was the HSE involved in the InterTradeIreland cross-Border meet the buyer event at the RDS?

Public Accounts Committee: Health Service Executive Financial Statements 2014
2014 Annual Report and Appropriation Accounts of the Comptroller and Auditor General
Vote 39: Health Service Executive
Chapter 19: Compliance with Prompt Payment Legislation in the Health Sector
Chapter 20: Management of Private Patient Income in the Health Sector
Chapter 21: Control over the Supply of High-Tech Drugs and Medicines (22 Oct 2015)

John Perry: On value for money, which is the adjudication of the committee, how do the HSE’s reports stack up?

Public Accounts Committee: Health Service Executive Financial Statements 2014
2014 Annual Report and Appropriation Accounts of the Comptroller and Auditor General
Vote 39: Health Service Executive
Chapter 19: Compliance with Prompt Payment Legislation in the Health Sector
Chapter 20: Management of Private Patient Income in the Health Sector
Chapter 21: Control over the Supply of High-Tech Drugs and Medicines (22 Oct 2015)

John Perry: Does the HSE have any connection with Mr. Paul Quinn of the OGP?

Public Accounts Committee: Health Service Executive Financial Statements 2014
2014 Annual Report and Appropriation Accounts of the Comptroller and Auditor General
Vote 39: Health Service Executive
Chapter 19: Compliance with Prompt Payment Legislation in the Health Sector
Chapter 20: Management of Private Patient Income in the Health Sector
Chapter 21: Control over the Supply of High-Tech Drugs and Medicines (22 Oct 2015)

John Perry: What role does the OGP have in the roll-out of Mr. Swords’s job as head of procurement?

Public Accounts Committee: Health Service Executive Financial Statements 2014
2014 Annual Report and Appropriation Accounts of the Comptroller and Auditor General
Vote 39: Health Service Executive
Chapter 19: Compliance with Prompt Payment Legislation in the Health Sector
Chapter 20: Management of Private Patient Income in the Health Sector
Chapter 21: Control over the Supply of High-Tech Drugs and Medicines (22 Oct 2015)

John Perry: Does Mr. Quinn have autonomy over the procurement rules and procedures?

Public Accounts Committee: Health Service Executive Financial Statements 2014
2014 Annual Report and Appropriation Accounts of the Comptroller and Auditor General
Vote 39: Health Service Executive
Chapter 19: Compliance with Prompt Payment Legislation in the Health Sector
Chapter 20: Management of Private Patient Income in the Health Sector
Chapter 21: Control over the Supply of High-Tech Drugs and Medicines (22 Oct 2015)

John Perry: Are all services procured by Mr. Swords’s office put up on eTenders?

Public Accounts Committee: Health Service Executive Financial Statements 2014
2014 Annual Report and Appropriation Accounts of the Comptroller and Auditor General
Vote 39: Health Service Executive
Chapter 19: Compliance with Prompt Payment Legislation in the Health Sector
Chapter 20: Management of Private Patient Income in the Health Sector
Chapter 21: Control over the Supply of High-Tech Drugs and Medicines (22 Oct 2015)

John Perry: What is Mr. Swords's opinion on the General Medical Services, GMS, system with the pharmacies and the demand-led system?

Public Accounts Committee: Health Service Executive Financial Statements 2014
2014 Annual Report and Appropriation Accounts of the Comptroller and Auditor General
Vote 39: Health Service Executive
Chapter 19: Compliance with Prompt Payment Legislation in the Health Sector
Chapter 20: Management of Private Patient Income in the Health Sector
Chapter 21: Control over the Supply of High-Tech Drugs and Medicines (22 Oct 2015)

John Perry: A question was raised in the Comptroller and Auditor General's report about the stock on order and the just-in-time principle. Does the HSE operate the just-in-time principle in the delivery of drugs to pharmacies, which is very important?